Intuitive Surgical, Inc. (ISRG) Stock Moves -0.22%: What You Should Know

Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $507.90, moving -0.22% from the previous trading session. The stock outperformed the S&P 500, which registered a daily loss of 0.33%. On the other hand, the Dow registered a loss of 0.37%, and the technology-centric Nasdaq decreased by 0.53%.The company's stock has dropped by 12.38% in the past month, falling short of the Medical sector's loss of 3.24% and the S&P 500's loss of 4.03%.The investment community will be paying close attention to the earnings performance of Intuitive Surgical, Inc. in its upcoming release. The company is slated to reveal its earnings on April 22, 2025. On that day, Intuitive Surgical, Inc. is projected to report earnings of $1.71 per share, which would represent year-over-year growth of 14%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.18 billion, up 15.42% from the year-ago period.For the full year, the Zacks Consensus Estimates project earnings of $7.97 per share and a revenue of $9.56 billion, demonstrating changes of +8.58% and +14.42%, respectively, from the preceding year.It is also important to note the recent changes to analyst estimates for Intuitive Surgical, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been a 0.02% fall in the Zacks Consensus EPS estimate. Intuitive Surgical, Inc. currently has a Zacks Rank of #3 (Hold).Looking at its valuation, Intuitive Surgical, Inc. is holding a Forward P/E ratio of 63.85. This signifies a premium in comparison to the average Forward P/E of 27.74 for its industry.We can also see that ISRG currently has a PEG ratio of 3.96. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As the market closed yesterday, the Medical - Instruments industry was having an average PEG ratio of 2.51.The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 71, which puts it in the top 29% of all 250+ industries.The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks